Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
Conditions: Coronavirus; COVID; Pneumonia Interventions: Drug: Darunavir/Cobicistat; Drug: Lopinavir/Ritonavir Sponsor: Hamad Medical Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Coronavirus | COVID-19 | Kaletra | Middle East Health | Norvir | Pneumonia | Prezista | Qatar Health | Research